Jazz Pharmaceuticals
JAZZ
$110.48
Share price
-1.37%
Change (1 day)
-17.97%
Change (1 year)
Categories
P/S ratio for Jazz Pharmaceuticals (JAZZ)
P/S ratio as of May 2024 (TTM): 1.84
According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.8372. At the end of 2023 the company had a P/S ratio of 2.02.
P/S ratio history for Jazz Pharmaceuticals from 2007 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.02 | -26.32% |
| 2022 | 2.74 | 8.31% |
| 2021 | 2.53 | -35.48% |
| 2020 | 3.92 | 1.18% |
| 2019 | 3.88 | 2.84% |
| 2018 | 3.77 | -24.41% |
| 2017 | 4.99 | 13.64% |
| 2016 | 4.39 | -32.53% |
| 2015 | 6.50 | -23.17% |
| 2014 | 8.47 | 0.87% |
| 2013 | 8.39 | 59.2% |
| 2012 | 5.27 | -11.86% |
| 2011 | 5.98 | 32.17% |
| 2010 | 4.53 | 136.01% |
| 2009 | 1.92 | 173.21% |
| 2008 | 0.7018 | -87.3% |
| 2007 | 5.53 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.24 | 130.73% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | 0.1421 | -92.27% | 🇺🇸 USA |
 Endo International
ENDPQ | 0.0001 | -100.00% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | 1.22 | -33.51% | 🇮🇱 Israel |